The Net Margin of Hansa Biopharma AB (HNSA.ST) is -471.20%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -471.20% |
| 2023-12-31 | -620.25% |
| 2022-12-31 | -395.49% |
| 2021-12-31 | -1618.40% |
| 2020-12-31 | -6901.49% |
| 2019-12-31 | -10701.81% |
| 2018-12-31 | -7384.57% |
| 2017-12-31 | -5132.48% |
| 2016-12-31 | -4309.00% |
| 2015-12-31 | -992.75% |